Markers for the progression of IgA nephropathy

Role of IgA receptors in the pathogenesis of IgA nephropathy

(2015) Sebastian M. Lechner et al.   JOURNAL OF NEPHROLOGY

Role of complement in IgA nephropathy

(2015) Mohamed R. Daha et al.   JOURNAL OF NEPHROLOGY

Current Understanding of the Role of Complement in IgA Nephropathy

(2015) N. Maillard et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis

(2015) Sean J. Barbour et al.   KIDNEY INTERNATIONAL

Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes

(2015) Laureline Berthelot et al.   KIDNEY INTERNATIONAL

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy

(2015) Junichi Yasutake et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Identification of new susceptibility loci for IgA nephropathy in Han Chinese

(2015) Ming Li et al.   Nature Communications

Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy

(2015) Nannan Wang et al.   PeerJ

Novel Biomarkers in Glomerular Disease

(2014) Yasar Caliskan et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Cytokines Alter IgA1O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes

(2014) Hitoshi Suzuki et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy

(2014) R. Schmitt et al.   JOURNAL OF IMMUNOLOGY

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

(2014) Rosanna Coppo et al.   KIDNEY INTERNATIONAL

Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

(2014) Krzysztof Kiryluk et al.   NATURE GENETICS

MicroRNAs in IgA nephropathy

(2014) Cheuk-Chun Szeto et al.   Nature Reviews Nephrology

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy

(2014) Junichiro Nakata et al.   PLoS One

Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan

(2014) Takahito Moriyama et al.   PLoS One

A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases

(2014) Hiroyuki Yanagawa et al.   PLoS One

Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch–Schönlein purpura nephritis

(2013) Sigurd E. Delanghe et al.   CLINICAL BIOCHEMISTRY

Association of Urinary Laminin G-Like 3 and Free K Light Chains with Disease Activity and Histological Injury in IgA Nephropathy

(2013) M. T. Rocchetti et al.   Clinical Journal of the American Society of Nephrology

Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy

(2013) Hiyori Suzuki et al.   JOURNAL OF NEPHROLOGY

MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy

(2013) Hao Bao et al.   KIDNEY INTERNATIONAL

IgA Nephropathy

(2013) Robert J. Wyatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Urinary Fractalkine and Monocyte Chemoattractant Protein-1 as Possible Predictors of Disease Activity of Childhood Glomerulonephritis

(2013) Tomomi Aizawa et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Risk Stratification of Patients With IgA Nephropathy

(2012) Sean J. Barbour et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy

(2012) L.-L. Liu et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy

(2012) Yukihiro Wada et al.   Clinical and Experimental Nephrology

Relationships between Levels of Urinary Podocalyxin, Number of Urinary Podocytes, and Histologic Injury in Adult Patients with IgA Nephropathy

(2012) R. Asao et al.   Clinical Journal of the American Society of Nephrology

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors

(2012) Laureline Berthelot et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Abnormal miR-148b Expression Promotes Aberrant Glycosylation of IgA1 in IgA Nephropathy

(2012) G. Serino et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy

(2012) F. Berthoux et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression

(2012) Na Zhao et al.   KIDNEY INTERNATIONAL

Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis

(2012) Krzysztof Kiryluk et al.   PLoS Genetics

The Use of the Oxford Classification of IgA Nephropathy to Predict Renal Survival

(2011) E. Alamartine et al.   Clinical Journal of the American Society of Nephrology

Predicting the Risk for Dialysis or Death in IgA Nephropathy

(2011) F. Berthoux et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Pathophysiology of IgA Nephropathy

(2011) H. Suzuki et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Genome-wide association study identifies susceptibility loci for IgA nephropathy

(2011) Ali G Gharavi et al.   NATURE GENETICS

The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience

(2011) D. Maixnerova et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy

(2011) H. P. E. Peters et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells

(2011) Jan Novak et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort

(2011) S. S. Bellur et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Galactose-Deficient IgA1 in African Americans with IgA Nephropathy: Serum Levels and Heritability

(2010) M. C. Hastings et al.   Clinical Journal of the American Society of Nephrology

Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy

(2010) Mai T. Vuong et al.   KIDNEY INTERNATIONAL

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults

(2010) Rosanna Coppo et al.   KIDNEY INTERNATIONAL

Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

(2010) David M. Good et al.   MOLECULAR & CELLULAR PROTEOMICS

Identification of a uromodulin fragment for diagnosis of IgA nephropathy

(2010) Jie Wu et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

(2009) Hitoshi Suzuki et al.   JOURNAL OF CLINICAL INVESTIGATION

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

(2009) Ian S.D. Roberts et al.   KIDNEY INTERNATIONAL

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

(2009) Daniel C. Cattran et al.   KIDNEY INTERNATIONAL

Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy

(2008) S. Shimozato et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy

(2007) D.D. Torres et al.   KIDNEY INTERNATIONAL